Please login to the form below

Not currently logged in
Email:
Password:

Eric Rhodes becomes CEO of ERS Genomics

Succeeds the company’s founder Shaun Foy in the role

ERS Genomics Eric RhodesERS Genomics, an Irish biotechnology firm, has appointed Eric Rhodes as its new chief executive officer.

He replaces co-founder Shaun Foy in the lead role, who will continue on with the company as chairman of the board.

Rhodes joins ERS Genomics from Horizon Discovery, where he served as senior vice president of research and development and chief technology officer.

In these roles, Rhodes was responsible for commercialising the company's genome editing technologies as well as driving its research and development.

Prior to joining Horizon Discovery, Rhodes held a number of senior positions including director of business development at Sigma-Aldrich and vice president of business development and alliance management at Sangamo Biosciences.

Foy said: “With his deep understanding of the gene-editing landscape and extensive experience in marketing and commercialising gene-editing technologies, Eric is a perfect fit to help ERS Genomics accelerate our commercialisation activities.

“We are excited to welcome him to the team.”

10th June 2016

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Medscape Education Global

Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide....

Latest intelligence

dementia
Alzheimer’s Research UK highlights socio-economic inequalities in dementia risk
The charity aims to improve the number of women participating in dementia research and grow awareness of dementia risk factors...
Data security
Concerns about data security are building a strong case for clinical mobility in EMEA
Electronic medical records have transformed the storage of sensitive information but how can the healthcare sector continue to protect patient and staff data?...
Mainimage2
The role of digital health technology tools in supporting medical adherence
How DHT-based digital interventions can help to support patients and improve adherence...